You Searched For: Cell Culture Supplements and Additives
2 988 results were found
~~29188433AA Production of recombinant monoclonal an~~
/m-de.vwr.com/de_DE/images/29188433AA_Production_of_recombinant_monoclonal_an.pdf
1.0 0.9 0.8 0.7 0.6 0.5 rM A b (g /L ) 0.4 0.3 0.2 0.1 0 10 9 8 7 6 5 C el l d en si ty (c el ls /m L) 4 3 2 1 0 0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 Time (d) Feed Application note 29188433 AA GE Healthcare Production of recombinant monoclonal antib...
~~29188433AA Production of recombinant monoclonal an~~
/m-si.vwr.com/sl_SI/images/29188433AA_Production_of_recombinant_monoclonal_an.pdf
1.0 0.9 0.8 0.7 0.6 0.5 rM A b (g /L ) 0.4 0.3 0.2 0.1 0 10 9 8 7 6 5 C el l d en si ty (c el ls /m L) 4 3 2 1 0 0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 Time (d) Feed Application note 29188433 AA GE Healthcare Production of recombinant monoclonal antib...
~~29188433AA Production of recombinant monoclonal an~~
/m-dk.vwr.com/da_DK/images/29188433AA_Production_of_recombinant_monoclonal_an.pdf
1.0 0.9 0.8 0.7 0.6 0.5 rM A b (g /L ) 0.4 0.3 0.2 0.1 0 10 9 8 7 6 5 C el l d en si ty (c el ls /m L) 4 3 2 1 0 0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 Time (d) Feed Application note 29188433 AA GE Healthcare Production of recombinant monoclonal antib...
~~29188433AA Production of recombinant monoclonal an~~
/m-it.vwr.com/it_IT/images/29188433AA_Production_of_recombinant_monoclonal_an.pdf
1.0 0.9 0.8 0.7 0.6 0.5 rM A b (g /L ) 0.4 0.3 0.2 0.1 0 10 9 8 7 6 5 C el l d en si ty (c el ls /m L) 4 3 2 1 0 0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 Time (d) Feed Application note 29188433 AA GE Healthcare Production of recombinant monoclonal antib...
29188433AA Production of recombinant monoclonal an
/m-ch.vwr.com/it_CH/images/29188433AA_Production_of_recombinant_monoclonal_an.pdf
1.0 0.9 0.8 0.7 0.6 0.5 rM A b (g /L ) 0.4 0.3 0.2 0.1 0 10 9 8 7 6 5 C el l d en si ty (c el ls /m L) 4 3 2 1 0 0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 Time (d) Feed Application note 29188433 AA GE Healthcare Production of recombinant monoclonal antib...
~~29188433AA Production of recombinant monoclonal an~~
/m-nl.vwr.com/nl_NL/images/29188433AA_Production_of_recombinant_monoclonal_an.pdf
1.0 0.9 0.8 0.7 0.6 0.5 rM A b (g /L ) 0.4 0.3 0.2 0.1 0 10 9 8 7 6 5 C el l d en si ty (c el ls /m L) 4 3 2 1 0 0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 Time (d) Feed Application note 29188433 AA GE Healthcare Production of recombinant monoclonal antib...
~~29188433AA Production of recombinant monoclonal an~~
/m-no.vwr.com/no_NO/images/29188433AA_Production_of_recombinant_monoclonal_an.pdf
1.0 0.9 0.8 0.7 0.6 0.5 rM A b (g /L ) 0.4 0.3 0.2 0.1 0 10 9 8 7 6 5 C el l d en si ty (c el ls /m L) 4 3 2 1 0 0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 Time (d) Feed Application note 29188433 AA GE Healthcare Production of recombinant monoclonal antib...
~~29188433AA Production of recombinant monoclonal an~~
/m-pl.vwr.com/pl_PL/images/29188433AA_Production_of_recombinant_monoclonal_an.pdf
1.0 0.9 0.8 0.7 0.6 0.5 rM A b (g /L ) 0.4 0.3 0.2 0.1 0 10 9 8 7 6 5 C el l d en si ty (c el ls /m L) 4 3 2 1 0 0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 Time (d) Feed Application note 29188433 AA GE Healthcare Production of recombinant monoclonal antib...
~~29188433AA Production of recombinant monoclonal an~~
/m-in.vwr.com/en_IN/images/29188433AA_Production_of_recombinant_monoclonal_an.pdf
1.0 0.9 0.8 0.7 0.6 0.5 rM A b (g /L ) 0.4 0.3 0.2 0.1 0 10 9 8 7 6 5 C el l d en si ty (c el ls /m L) 4 3 2 1 0 0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 Time (d) Feed Application note 29188433 AA GE Healthcare Production of recombinant monoclonal antib...
CLS-AN-446-A4-DL
/m-sk.vwr.com/sk_SK/images/CLS-AN-446-A4-DL.pdf
Considerations for Three-Dimensional Cell Culture when using the Corning® Spheroid Microplate Guidelines for Use There has been a growing interest in three dimensional (3D) cell culture with more data showing drastic differences in cell behavior a...
CLS-AN-446-A4-DL
/m-uk.vwr.com/en_GB/images/CLS-AN-446-A4-DL.pdf
Considerations for Three-Dimensional Cell Culture when using the Corning® Spheroid Microplate Guidelines for Use There has been a growing interest in three dimensional (3D) cell culture with more data showing drastic differences in cell behavior a...
29271856AA maximize performance with sfm selection
/m-ch.vwr.com/it_CH/images/29271856AA_maximize_performance_with_sfm_selection.pdf
Maximize performance with HyClone™ media and supplements gelifesciences.com 3 of 4 Maximize performance with HyClone media and supplements serum Maximize performance with HyClone media and supplements serum 3 of 4 Boost performance. Strengthen res...
CLS-AN-446-A4-DL
/m-cz.vwr.com/cs_CZ/images/CLS-AN-446-A4-DL.pdf
Considerations for Three-Dimensional Cell Culture when using the Corning® Spheroid Microplate Guidelines for Use There has been a growing interest in three dimensional (3D) cell culture with more data showing drastic differences in cell behavior a...
CLS-AN-446-A4-DL
/m-ch.vwr.com/de_CH/images/CLS-AN-446-A4-DL.pdf
Considerations for Three-Dimensional Cell Culture when using the Corning® Spheroid Microplate Guidelines for Use There has been a growing interest in three dimensional (3D) cell culture with more data showing drastic differences in cell behavior a...
~~CLS-AN-446-A4-DL~~
/m-cn.vwr.com/zh_CN/images/CLS-AN-446-A4-DL.pdf
Considerations for Three-Dimensional Cell Culture when using the Corning® Spheroid Microplate Guidelines for Use There has been a growing interest in three dimensional (3D) cell culture with more data showing drastic differences in cell behavior a...
~~29271856AA maximize performance with sfm selection~~
/m-be.vwr.com/nl_BE/images/29271856AA_maximize_performance_with_sfm_selection.pdf
Maximize performance with HyClone™ media and supplements gelifesciences.com 3 of 4 Maximize performance with HyClone media and supplements serum Maximize performance with HyClone media and supplements serum 3 of 4 Boost performance. Strengthen res...
1 - 16 of 2 988